Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
Conditions: HIV; Tuberculosis Interventions: Drug: Clofazimine (CFZ); Drug: Rifapentine (RPT); Drug: Isoniazid (INH); Drug: Pyrazinamide (PZA); Drug: Ethambutol (EMB); Drug: Rifampicin (RIF); Dietary Supplement: Pyridoxine (vitamin B6) Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Infectious Diseases | Nutrition | Research | Study | Tuberculosis